Daub, Marlon F.

HRN: 22-82-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2023
METRONIDAZOLE 500MG (TAB)
04/16/2023
04/19/2023
ORAL
500 Mg
Q8
Amoebic Abcess
Waiting Final Action 

Indication:  Empirical EscalationEmpirical De-escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: